KZA kazia therapeutics limited

Ann: Appendix 4C - quarterly, page-9

  1. 1,093 Posts.
    lightbulb Created with Sketch. 122
    To me, these look like subtle warnings to Kazia investors. From todays quarterly report:

    "it is difficult to draw inferences as to the anticipated expenditure in FY2021"

    "Should it be required, the company has contingency plans in place to adjust operational execution of its studies and, as necessary, to conserve cash"

    I am just thinking aloud and of course this is not advice

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.